Data presented at American Academy of Neurology’s 66th Annual Meeting shows diagnostic effectiveness of DaTscanTM (Ioflupane I1

30-04-2014 Business Wire HealthComments (0)

BiotechnologyNeurologicalUSA

Data from a pooled analysis of four clinical trials, presented today at the American Academy of Neurology’s 66th Annual Meeting in Philadelphia, showed that using DaTscan™ (Ioflupane I 123 Injection) with single-photon emission computed tomography (SPECT) brain imaging was associated with a high level of diagnostic effectiveness.1 The analysis showed high overall sensitivity and specificity of DaTscan images to detect a striatal dopaminergic deficit, which is

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top